| Apr-18-22 12:45PM |
Exelixis (EXEL) Initiates Early Stage Study of Lymphoma |
Zacks |
| Apr-08-22 12:18PM |
Kaleido Biosciences Shares Plunging To 52-Week Low, Read Why |
Benzinga |
| Apr-01-22 08:48AM |
Novartis (NVS) Beovu Gets Label Expansion for DME in EU |
Zacks |
| Mar-31-22 09:15AM |
Dare Bioscience, Inc. (DARE) Reports Q4 Loss, Misses Revenue Estimates |
Zacks |
| Mar-30-22 11:19AM |
Roche (RHHBY) Late-Stage Study for ES-SCLC Fails to Meet Goal |
Zacks |
| Mar-29-22 11:38AM |
Bristol Myers (BMY) Application for Opdivo With Chemo Validated |
Zacks |
| Mar-28-22 01:27PM |
Novartis (NVS) Gets Positive CHMP Opinion for Jakafi, Kymriah |
Zacks |
| Mar-28-22 11:56AM |
Bristol (BMY) Label Expansion of Reblozyl Delayed by 3 Months |
Zacks |
| Mar-25-22 11:49AM |
Bristol Myers (BMY) Gains 16% YTD: Will the Momentum Continue? |
Zacks |
| Mar-24-22 02:02PM |
Rezolute (RZLT) Posts Positive Data From Congenital HI Study |
Zacks |
| Mar-23-22 11:40AM |
ORIC Stock Plunges on Discontinuation of Oncology Candidate |
Zacks |
| Mar-21-22 11:23AM |
Bristol Myers' (BMY) Opdualag Wins FDA Nod for Melanoma |
Zacks |
| Mar-16-22 08:30AM |
Radius Health Announces Leadership Appointments |
GlobeNewswire |
| Mar-15-22 05:15PM |
Adicet Bio, Inc. (ACET) Reports Q4 Loss, Tops Revenue Estimates |
Zacks |
| Mar-15-22 11:35AM |
AnaptysBio's (ANAB) Acne Study on Imsidolimab Fails to Meet Goal |
Zacks |
| Mar-10-22 11:50AM |
Acadia (ACAD) Stock Up on FDA's Action Date for Nuplazid sNDA |
Zacks |
| Mar-07-22 05:32PM |
FDA Nods to Bristol Myers' (BMY) Opdivo for Additional Indication |
Zacks |
| Mar-02-22 10:12AM |
Horizon (HZNP) Q4 Earnings Beat Estimates, Revenues Rise Y/Y |
Zacks |
| Mar-01-22 09:43AM |
Acadia (ACAD) Q4 Earnings & Revenues Fall Shy of Estimates |
Zacks |
| Feb-28-22 09:00AM |
Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs |
PR Newswire |
| Feb-24-22 11:14AM |
Global Blood's (GBT) Q4 Earnings Miss Mark, Revenues Rise Y/Y |
Zacks |
| Feb-23-22 03:00PM |
Kaleido Biosciences, Inc. (KLDO) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release |
Zacks |
| Feb-23-22 11:11AM |
Novavax (NVAX) to Report Q4 Earnings: What's in the Cards? |
Zacks |
| Feb-22-22 09:32AM |
Is a Beat Likely for Perrigo (PRGO) This Earnings Season? |
Zacks |
| Feb-17-22 11:30AM |
Blueprint Medicines (BPMC) Q4 Loss Widens, Revenues Top Mark |
Zacks |
| Feb-15-22 10:14AM |
10 Cheap Pharmaceutical Stocks For 2022 |
Insider Monkey |
| Feb-15-22 10:05AM |
INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT |
PR Newswire |
| Feb-04-22 10:00AM |
Here's Why Kaleido Biosciences, Inc. (KLDO) is Poised for a Turnaround After Losing 33.2% in 4 Weeks |
Zacks |
| Jan-31-22 05:40AM |
Kaleido Halts Upcoming Phase 2 COPD Trial, Piper Sandler Cuts Price Target |
Benzinga |
| Jan-21-22 11:04AM |
Kaleido Biosciences to Present Updated Data of KB295 In Ulcerative Colitis at the 2022 Crohns and Colitis Congress |
GlobeNewswire |
| Jan-05-22 06:54AM |
Kaleido Biosciences, Inc. (KLDO) Sees Hammer Chart Pattern: Time to Buy? |
Zacks |
| Dec-16-21 11:38PM |
Fidelity Salem Street Trust Buys AMC Entertainment Holdings Inc, E2open Parent Holdings Inc, ... |
GuruFocus.com |
| Dec-06-21 07:30AM |
Kaleido Biosciences Announces Expansion of Collaboration with Janssen to Explore Potential of Microbiome Metabolic Therapies (MMT) to Prevent Childhood-Onset of Atopic, Immune and Metabolic Conditions |
GlobeNewswire |
| Nov-15-21 07:30AM |
Kaleido Biosciences to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference |
GlobeNewswire |
| Nov-10-21 07:30AM |
Kaleido Biosciences to Appoint Dr. Alison Long as Chief Medical Officer |
GlobeNewswire |
| Nov-01-21 09:17AM |
Here's Why Kaleido Biosciences, Inc. (KLDO) Is a Great 'Buy the Bottom' Stock Now |
Zacks |
| Nov-01-21 08:45AM |
Kaleido Biosciences, Inc. (KLDO) Reports Q3 Loss, Misses Revenue Estimates |
Zacks |
| Nov-01-21 07:30AM |
Kaleido Biosciences Reports Third Quarter 2021 Financial Results |
GlobeNewswire |
| Oct-28-21 10:00AM |
Down 23.6% in 4 Weeks, Here's Why Kaleido Biosciences, Inc. (KLDO) Looks Ripe for a Turnaround |
Zacks |
| Oct-25-21 03:01PM |
Kaleido Biosciences, Inc. (KLDO) May Report Negative Earnings: Know the Trend Ahead of Q3 Release |
Zacks |
| Oct-13-21 10:00AM |
Invaio Sciences Secures $50 Million Debt Financing to Develop and Commercialize Agricultural Solutions to Address Climate Change |
PR Newswire |
| Oct-12-21 07:30AM |
Kaleido Biosciences to Participate in the Jefferies Virtual Next Generation IBD Therapeutics Summit |
GlobeNewswire |
| Oct-05-21 02:30PM |
Mid-Afternoon Market Update: Dow Jumps 450 Points; Comtech Telecommunications Shares Slide |
Benzinga |
| Oct-05-21 12:15PM |
Mid-Day Market Update: Crude Oil Rises 2%; UpHealth Shares Plunge |
Benzinga |
| Oct-05-21 08:01AM |
The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout |
Benzinga |
| Oct-05-21 07:00AM |
Kaleido Biosciences Announces New Clinical and Preclinical Data Supporting Advancement of KB295 to a Phase 2 Clinical Study in Mild-to-Moderate Ulcerative Colitis |
GlobeNewswire |
| Sep-29-21 07:30AM |
Kaleido Biosciences to Host Virtual R&D Presentation to Discuss Clinical Data and Pipeline Advancement on October 5, 2021 |
GlobeNewswire |
| Sep-23-21 09:48AM |
Those who invested in Kaleido Biosciences (NASDAQ:KLDO) a year ago are up 12% |
Simply Wall St. |
| Sep-07-21 01:20PM |
FDA Questions Kaleido Biosciences 'Non-IND' COVID-19 Trial |
Benzinga |
| Sep-02-21 07:30AM |
Kaleido Biosciences to Participate in the Morgan Stanley 19th Annual Virtual Global Healthcare Conference |
GlobeNewswire |
| Aug-11-21 08:55AM |
Kaleido Biosciences, Inc. (KLDO) Reports Q2 Loss, Lags Revenue Estimates |
Zacks |
| Aug-11-21 07:30AM |
Kaleido Biosciences Reports Second Quarter 2021 Financial Results |
GlobeNewswire |
| Aug-10-21 07:30AM |
Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial |
GlobeNewswire |
| Aug-09-21 04:15PM |
Kaleido Biosciences Announces New Chairperson Appointment to its Board of Directors |
GlobeNewswire |
| Aug-06-21 07:30AM |
Kaleido Biosciences to Participate in the 41st Annual Canaccord Genuity Growth Conference |
GlobeNewswire |
| Jul-27-21 03:03PM |
Kaleido Biosciences, Inc. (KLDO) May Report Negative Earnings: Know the Trend Ahead of Q2 Release |
Zacks |
| Jun-30-21 10:08AM |
Is Kaleido BioSciences, Inc. (KLDO) A Good Stock To Buy? |
Insider Monkey |
| Jun-10-21 07:30AM |
Kaleido Biosciences to Participate in the JMP Securities Life Sciences Conference |
GlobeNewswire |
| Jun-03-21 04:32AM |
Have Insiders Been Buying Kaleido Biosciences, Inc. (NASDAQ:KLDO) Shares This Year? |
Simply Wall St. |
| May-25-21 06:00AM |
Invaio Sciences Raises $88.9 Million to Accelerate the Transition to Biological Agriculture |
PR Newswire |
| May-19-21 09:01AM |
Invaio Sciences Announces Key Agreement with Fundecitrus in Brazil to Combat Against Citrus Greening |
PR Newswire |
| May-04-21 07:30AM |
Kaleido Biosciences Reports First Quarter 2021 Financial Results |
GlobeNewswire |
| Apr-20-21 07:30AM |
Kaleido Biosciences Announces Collaboration with Robert Jenq, M.D., to Explore Potential of its Microbiome Metabolic Therapies (MMT) in Preventing Febrile Neutropenia |
GlobeNewswire |
| Apr-15-21 07:30AM |
Kaleido Biosciences to Participate in Jefferies Microbiome-Based Therapeutics Summit |
GlobeNewswire |
| Apr-06-21 02:43PM |
Biotech company Kaleido develops oral therapy for COVID-19 |
Yahoo Finance Video |
| Apr-01-21 12:24PM |
CytoDyn (CYDY) Files New Protocol With FDA for COVID-19 Study |
Zacks |
| Mar-31-21 01:33PM |
Biotech Stock Roundup: BLUE/BMY's CAR T Therapy Nod, KLDO's COVID-19 Study News & More |
Zacks |
| Mar-30-21 09:30AM |
Invaio Sciences Strengthens Leadership Team with Appointment of Peleg Chevion as President and Chief Commercial Officer |
PR Newswire |
| Mar-25-21 06:10PM |
Kaleido (KLDO) Reports Positive Results from COVID-19 Study |
Zacks |
| Mar-24-21 08:34AM |
Kaleido Biosciences Stock Is Trading Higher On Positive KB109 Data In COVID-19 Study |
Benzinga |
| Mar-24-21 07:00AM |
Kaleido Biosciences says oral drug cuts COVID-19 recovery time, hospitalizations |
Reuters |
| Mar-24-21 07:00AM |
Kaleido Biosciences Reports Positive Results from Non-IND Study Demonstrating a Reduction in COVID-19 Related Healthcare Utilization and Recovery Time in Patients with Mild-to-Moderate COVID-19 and One or More Comorbidity |
GlobeNewswire |
| Mar-03-21 07:35AM |
Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results |
GlobeNewswire |
| Mar-01-21 07:30AM |
Kaleido Biosciences to Present at Chardans 3rd Annual Microbiome Medicines Summit |
GlobeNewswire |
| Feb-11-21 01:11PM |
Kaleido Biosciences Announces the Exercise of the Underwriters Option to Purchase Additional Shares of Common Stock |
GlobeNewswire |
| Feb-09-21 10:09AM |
Benzinga's Top Ratings Upgrades, Downgrades For February 9, 2021 |
Benzinga |
| Feb-09-21 02:50AM |
What Is The Ownership Structure Like For Kaleido Biosciences, Inc. (NASDAQ:KLDO)? |
Simply Wall St. |
| Feb-03-21 10:03PM |
Kaleido Biosciences Announces Pricing of Public Offering of Common Stock |
GlobeNewswire |
| Feb-03-21 04:10PM |
Kaleido Biosciences Announces Proposed Public Offering of Common Stock |
GlobeNewswire |
| Jan-20-21 07:30AM |
Kaleido Biosciences to Present at the Keystone Symposium Harnessing the Microbiome for Disease Prevention and Therapy Conference |
GlobeNewswire |
| Jan-14-21 07:30AM |
Kaleido Biosciences Announces Positive Interim Results of Controlled Study of KB109 in Patients with Mild-to-Moderate COVID-19 |
GlobeNewswire |
| Jan-05-21 07:30AM |
Kaleido Biosciences to Present at the 39th Annual J.P. Morgan Healthcare Conference |
GlobeNewswire |
| Jan-04-21 07:30AM |
Kaleido Biosciences Announces Completion of Enrollment of 350 Subjects in Controlled Study of KB109 in the Treatment of Mild-to-Moderate COVID-19 |
GlobeNewswire |
| Dec-23-20 10:07AM |
Benzinga's Top Upgrades, Downgrades For December 23, 2020 |
Benzinga |
| Nov-24-20 03:00PM |
Kaleido Biosciences to Present at the Piper Sandler 32nd Annual Virtual Healthcare Conference |
GlobeNewswire |
| Nov-13-20 09:23AM |
New Strong Sell Stocks for November 13th |
Zacks |
| Nov-02-20 07:35AM |
Kaleido Biosciences Reports Third Quarter 2020 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Oct-23-20 07:31AM |
Analysts Have Just Cut Their Kaleido Biosciences, Inc. (NASDAQ:KLDO) Revenue Estimates By 20% |
Simply Wall St. |
| Oct-07-20 07:30AM |
Kaleido Biosciences Announces Data from MMT Programs Accepted for Presentation at Upcoming Scientific Conferences |
GlobeNewswire |
| Oct-06-20 07:30AM |
Kaleido Biosciences Provides Update on KB109 Clinical Data Timeline |
GlobeNewswire |
| Oct-02-20 12:09PM |
Kaleido's Unscreen is dead simple drag-and-drop background removal for video |
TechCrunch |
| Oct-01-20 07:30AM |
Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer |
GlobeNewswire |
| Sep-29-20 07:30AM |
Kaleido Biosciences Announces First Patient Dosed in Clinical Study of Microbiome Metabolic Therapy KB295 in Patients with Mild-to-Moderate Ulcerative Colitis |
GlobeNewswire |
| Sep-09-20 07:00AM |
Kaleido Biosciences to Present at Upcoming September Investor Conferences |
GlobeNewswire |
| Aug-27-20 07:00AM |
Kaleido Biosciences Announces Presentation of Data for Microbiome Metabolic Therapy KB174 for Hepatic Encephalopathy at The Digital International Liver Congress (EASL) |
GlobeNewswire |
| Aug-06-20 11:26AM |
How Much Of Kaleido Biosciences, Inc. (NASDAQ:KLDO) Do Insiders Own? |
Simply Wall St. |
| Aug-05-20 08:00AM |
Kaleido Biosciences to Present at the Canaccord Genuity 40th Annual Growth Conference |
GlobeNewswire |
| Aug-04-20 07:35AM |
Kaleido Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update |
GlobeNewswire |
| Jul-23-20 07:00AM |
Kaleido Biosciences Initiates Controlled Clinical Study with Massachusetts General Hospital of Microbiome Metabolic Therapy KB109 in Outpatients with Mild-to-Moderate COVID-19 |
GlobeNewswire |
| Jul-07-20 08:00AM |
Flagship Pioneering's Scientists Invent a New Category of Genome Engineering Technology: Gene Writing |
PR Newswire |